Empagliflozin vs Tamoxifen

Empagliflozin vs Tamoxifen: Overview

This comparison examines the pharmacological differences between Empagliflozin and Tamoxifen.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Tamoxifen: Selective estrogen receptor modulator (SERM).

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Tamoxifen — 5-7 days.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Tamoxifen — C26H29NO.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Tamoxifen — 371.5150 g/mol.

Type: Empagliflozin — Small molecule; Tamoxifen — Small molecule.